Regulation of Neonatal Muscle Protein Synthesis
Regulation of Neonatal Muscle Protein Synthesis
批准号:
9925081
负责人:
TERESA A DAVIS
金额:
$42.29万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-15 至 2023-03-31
关键词:
AdultAgeAlanineAmino AcidsAttenuatedBasic ScienceBody CompositionBolus InfusionBranched-Chain Amino AcidsCell ProliferationCell divisionClosure by clampComplexConceptionsContinuous InfusionDataEffectivenessEnteralEnteral FeedingEnteral NutritionExhibitsFRAP1 geneFamily suidaeFatty acid glycerol estersFeedsGestational AgeGoalsGrowthHealthHormonesHospitalsHumanIndividualInfantInfusion proceduresInsulinKnowledgeLaboratoriesLeucineLifeMetabolicMetabolic syndromeMethodsMissionModalityModelingMuscleMuscle ProteinsMuscle satellite cellNeonatalNutrientNutritionalNutritional SupportObesityOutcomePancreasParenteral NutritionPatternPeriodicityPhysiologic pulsePremature BirthPremature InfantProcessProtein BiosynthesisProteinsPublic HealthPublishingRegimenRegulationResearchResistanceRiskScheduleSignal PathwaySignal TransductionSkeletal MuscleSmall for Gestational Age InfantStimulusSupplementationTestingThinnessTranscriptTranslatingTranslation InitiationUnited States National Institutes of HealthWeightWorkbasecostexperiencefeedingglucose metabolismimprovedindexinginnovationinsulin sensitivityinsulin signalingmetabolomicsmuscle formneonatenovelnutritionobesity riskprematurepreventprotein degradationpublic health relevanceresponsesatellite celltranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Most premature infants have experienced extrauterine growth restriction by hospital discharge. Many remain small to adulthood and incur short- and long-term costs to their metabolic health, including an increased risk for obesity. Our long-term goal is to identify strategies to optimize the nutritional management of premature infants. The objective of this application is to determine whether prematurity limits the anabolic response to feeding and if this is mitigated by optimizing feeding strategies to enhance the efficiency of nutrient use for anabolic processes. The central hypothesis is that prematurity reduces lean growth, particularly in small for gestational age (SGA) neonates, but lean growth can be improved by cyclical stimulation of mammalian target of rapamycin signaling imparted by either feeding on an intermittent bolus schedule, rather than continuously, or by ad- ministration of intermittent leucine pulses when continuous feeding must be prescribed. The hypothesis is based on data from the applicants' laboratories. The rationale is that understanding the fundamental mechanisms by which different modes of feeding modulate lean mass in early life has the potential to translate into practices that will improve lean growth of preterm infants. Guided by strong preliminary data, this hypothesis will be tested by pursuing three specific aims: 1) Determine if prematurity alters the protein synthetic response of muscle to feeding by blunting insulin- and amino acid-induced translation initiation; 2) Determine if lean growth is reduced in the preterm, particularly SGA, but is improved by intermittent bolus feeding rather than continuous feeding delivered either parenterally or enterally; and 3) Determine if intermittent leucine pulses enhance lean growth by stimulating protein synthesis and myonuclear accretion and reducing degradation in pre- term continuously fed neonates. We will determine body composition, growth rate, and muscle protein synthesis and degradation, satellite cell abundance and proliferation, amino acid and insulin signaling, metabolite and whole transcriptome profiles, and insulin and amino acid sensitivity in SGA preterm, appropriate for gestational age (AGA) preterm, and term pigs fed on an intermittent bolus schedule or continuously, either parenterally or enterally, and in those provided intermittent leucine pulses when continuously fed. The methods are established in the applicants' laboratories. The approach is innovative because it will examine in the preterm piglet model the coordinated response of muscle protein synthesis, degradation, myonuclear accretion, amino acid and insulin signaling, and metabolite and transcript profiles that regulate lean growth. The proposed work is unique because it is the first to comprehensively examine in a relevant preterm model the effectiveness of different feeding modalities including a novel leucine supplementation approach on component processes that determine muscle growth. The proposed research is significant because it is expected to advance our under- standing of how prematurity impacts the anabolic response to nutrition. The results will provide important novel information required for the optimization of the nutritional management of preterm infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leucine and HMB Supplementation in Early Life to Promote Muscle Growth at the Expense of Adipose Deposition
-
批准号:10228667
-
项目类别:
-
资助金额:$40.47万
-
财政年份:2019
-
负责人:TERESA A DAVIS
-
依托单位:
Leucine and HMB Supplementation in Early Life to Promote Muscle Growth at the Expense of Adipose Deposition
-
批准号:10005440
-
项目类别:
-
资助金额:$41.29万
-
财政年份:2019
-
负责人:TERESA A DAVIS
-
依托单位:
Leucine and HMB Supplementation in Early Life to Promote Muscle Growth at the Expense of Adipose Deposition
-
批准号:9795011
-
项目类别:
-
资助金额:$41.05万
-
财政年份:2019
-
负责人:TERESA A DAVIS
-
依托单位:
REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:10735768
-
项目类别:
-
资助金额:$61.75万
-
财政年份:2016
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:9262972
-
项目类别:
-
资助金额:$45.29万
-
财政年份:2016
-
负责人:TERESA A DAVIS
-
依托单位:
Leucine Supplementation to Promote Lean Growth in Early Life
-
批准号:8677929
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2012
-
负责人:TERESA A DAVIS
-
依托单位:
Leucine Supplementation to Promote Lean Growth in Early Life
-
批准号:8547087
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2012
-
负责人:TERESA A DAVIS
-
依托单位:
Leucine Supplementation to Promote Lean Growth in Early Life
-
批准号:8334836
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2012
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:2910892
-
项目类别:
-
资助金额:$23.57万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:6679891
-
项目类别:
-
资助金额:$33.35万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:6917860
-
项目类别:
-
资助金额:$32.49万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:7256346
-
项目类别:
-
资助金额:$28.22万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:2083993
-
项目类别:
-
资助金额:$12.46万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:6171601
-
项目类别:
-
资助金额:$23.17万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:6776500
-
项目类别:
-
资助金额:$32.57万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:7103397
-
项目类别:
-
资助金额:$29.12万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:2732903
-
项目类别:
-
资助金额:$13.32万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:6375041
-
项目类别:
-
资助金额:$23.77万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
Regulation of Neonatal Muscle Protein Synthesis
-
批准号:7895647
-
项目类别:
-
资助金额:$38.32万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
HORMONAL REGULATION OF NEONATAL MUSCLE PROTEIN SYNTHESIS
-
批准号:6511886
-
项目类别:
-
资助金额:$24.37万
-
财政年份:1996
-
负责人:TERESA A DAVIS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: